Cryo-Cell International (CCEL) Stock Forecast: StockMap's 2-Week Call
CCEL stock forecast: StockMap's model makes no two-week call on Cryo-Cell International after the Nov 19 close: its evidence is split, 3 reasons for and 12 against. Right in 2 of 6 two-week windows on CCEL since Aug 21; by chance, a call on the same dates was right 59% of the time.
Cryo-Cell International last closed at $4.15, -0.48% on the session.
Against the IVW growth benchmark the position is +1.85% over the forecast window.
Cryo-Cell International's market cap is $33.46M as of November 19, 2026.
No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -6 (too close to call).
Where CCEL sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 3 bullish and 12 bearish.
Agreement across those insights is 80%.
38 daily calls for CCEL so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Cryo-Cell International in the 62nd percentile on return on equity, where 100 is best.
Cryo-Cell International is classified under Health Care / Health Care Providers & Services.
StockMap tracks Cryo-Cell International as the 79th largest of the 87 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.
Across that group the current two-week reads are 52 Neutral, 18 Moderate Underperform, 12 Moderate Outperform and 5 Strong Underperform.
On that composite Cryo-Cell International ranks 44th of 87 in the group, against a group median of -0.06.